Sanofi Strengthens Neurology Pipeline with $470M Vigil Neuroscience Acquisition

Sanofi SA has finalized its acquisition of Vigil Neuroscience, Inc., enhancing its neurology pipeline with VG-3927, a promising Alzheimer's treatment, in a deal worth $470 million....